CMS’ annual Medicare Trustees Report serves as one of the most important indicators of the program’s financial health. It offers a long-term view of how Medicare is funded, how quickly costs are rising, and what challenges lie ahead. The 2026 report delivers the mixed message that Medicare remains financially stable in the near term and continues to provide coverage for nearly 70 million Americans however, significant long-term pressures are building beneath the surface. These pressures include the projected depletion of the Medicare Hospital Insurance Trust Fund, rapid spending on healthcare services and prescription drugs, increasing reliance on federal funding, and rising costs for beneficiaries and taxpayers.
In this article, we'll examine the report's most significant findings, explore what is driving Medicare's growing costs, and discuss why Trustees are urging Congress and the Administration to address these challenges sooner than later.
Medicare Continues to Grow as Demand for Healthcare Increases
Medicare remains one of the largest healthcare programs in the world. In 2025, it provided coverage to approximately 69.3 million Americans, including 62.2 million seniors and 7.1 million people with disabilities. Total Medicare spending exceeded $1.2 trillion, reflecting both higher enrollment and continued growth in healthcare utilization. More than half of beneficiaries (about 51%) now receive their benefits through private Medicare Advantage plans, rather than traditional Medicare.
Demographics remain one of the biggest factors driving future spending. The baby boomer generation continues to age into Medicare, increasing the number of beneficiaries while simultaneously reducing the ratio of workers to help finance the program through payroll taxes. According to the Trustees, the number of workers supporting each Medicare beneficiary is expected to continue declining over the coming decades, creating financial strain on Medicare's traditional funding model.
At the same time, beneficiaries are living longer and benefiting from new medical treatments, advanced therapies, and innovative prescription medications. While these advances improve health outcomes, they also contribute to higher healthcare spending across the Medicare program.
The Part A Trust Fund Is Projected to Be Depleted in 2033
The most closely watched finding in the report concerns Medicare Part A, also known as Hospital Insurance (HI). This portion of Medicare covers inpatient hospital care, skilled nursing facilities, hospice, and certain home health services. Unlike other parts of Medicare, Part A relies primarily on payroll tax revenue and trust fund reserves.
The Trustees project that the HI Trust Fund will be depleted in 2033, one quarter earlier than estimated in last year's report. Once reserves are exhausted, incoming revenues would cover only about 89% of scheduled Part A costs. While Medicare would continue operating, the program would no longer have sufficient resources to pay the full value of scheduled benefits without legislative intervention.
The HI Trust Fund's unfunded obligation over the next 75 years is estimated at approximately $4.2 trillion. In practical terms, achieving long-term solvency would require either a payroll tax increase from 2.9% to 3.46%, a 12% reduction in scheduled benefits, or some combination of revenue increases and spending reductions.
Several factors contributed to the financial forecast, including lower projected revenues from taxes on Social Security benefits and updated assumptions related to healthcare spending and Medicare Advantage enrollment.
Parts B and D Remain Solvent
While the financial outlook for Part A raises concerns, Medicare Parts B and D operate under a different financing structure. Because beneficiary premiums and federal government contributions are adjusted annually to meet expected expenses, these programs are projected to remain solvent indefinitely under current law.
However, solvency does not mean costs are under control.
Trustees project spending will grow by an average of 8.5% annually for Part B and 9.4% annually for Part D between 2026 and 2030. These growth rates exceed projected economic growth and underscore the increasing cost of providing healthcare coverage to Medicare beneficiaries.
Prescription drug spending continues to be a major driver. The report specifically highlights increased utilization of GLP-1 medications and high-cost specialty drugs as key reasons why Part D spending projections have increased compared to last year. These therapies are transforming treatment for obesity, diabetes, and other chronic conditions, but they also place new financial pressures on Medicare.
The report also identifies dramatic growth in spending for skin substitute products under Part B. Expenditures increased from just $0.8 billion in 2021 to $14.1 billion in 2025. New reimbursement policies taking effect in 2026 are expected to reduce those costs substantially, demonstrating how policy changes can influence healthcare spending patterns.
Medicare Is Becoming Increasingly Dependent on Federal Funding
Another important theme running throughout the report is Medicare's growing reliance on general federal revenues.
Historically, dedicated funding sources such as payroll taxes and beneficiary premiums covered a larger share of program costs. Today, an increasing portion of Medicare financing comes directly from federal government contributions. Trustees project this trend will continue throughout the coming decades.
As a result, Trustees issued a Medicare funding warning for the ninth consecutive year. Federal law requires this warning when more than 45% of Medicare spending is projected to come from general revenues rather than dedicated financing sources within the seven-year projection period. That threshold is expected to be exceeded beginning in fiscal year 2026.
The implications extend beyond Medicare itself. As federal contributions increase, Medicare will place growing pressure on the broader federal budget, potentially affecting funding priorities across government programs. By 2100, Medicare's government-financed portion is projected to consume a substantially larger share of federal income tax revenues than it does today.
Medicare Spending Will Continue to Outpace Economic Growth
Perhaps the most telling measure of Medicare's future impact is its share of the nation's economy.
In 2025, Medicare spending represented 3.9% of Gross Domestic Product (GDP). Under current-law projections, Medicare expenditures are expected to increase to 6.5% of GDP by 2050 and 7.5% of GDP by 2100.
Several factors contribute to this growth:
- More Americans becoming eligible for Medicare.
- Increased utilization of healthcare services as beneficiaries age.
- Continued advances in medical technology and treatment options.
- Rising prescription drug costs.
- Higher healthcare spending per beneficiary over time.
The Trustees also modeled an alternative scenario in which current provider payment constraints prove difficult to sustain. Under that scenario, Medicare spending could reach nearly 9.8% of GDP by 2100, highlighting the degree of uncertainty surrounding long-term healthcare costs.
What This Means for Beneficiaries and Taxpayers
The financial trends described in the report will ultimately affect everyone who relies on Medicare, including those contributing to its funding.
For beneficiaries, healthcare costs are projected to consume an increasing share of retirement income. Trustees estimate that average Part B and Part D premiums will rise from approximately 12% of the average Social Security benefit in 2026 to nearly 21% by the year 2100. When premiums and cost-sharing expenses are combined, Medicare-related out-of-pocket costs could consume roughly 41% of the average Social Security benefit by the end of the century.
Taxpayers will also shoulder a larger share of the burden. Government contributions to Medicare are projected to rise significantly over time, increasing pressure on the federal budget and making Medicare an even more important fiscal policy issue in the decades ahead.
Healthcare providers face their own challenges. The report notes that current payment updates for many provider types are assumed to grow more slowly than healthcare costs. If those payment levels prove insufficient to maintain provider participation and access to care, future policymakers may need to revisit reimbursement policies, potentially increasing overall program costs.
Conclusion
The 2026 Medicare Trustees Report reinforces that Medicare remains strong today, but its long-term finances require attention. The projected depletion of the Hospital Insurance Trust Fund in 2033, continued growth in Part B and Part D spending, increased dependence on federal funding, and rising costs for beneficiaries all point to the need for thoughtful policy reforms.
It is important to note the report does not suggest an immediate crisis. The challenge facing policymakers is not whether Medicare will need changes—it is how those changes can be implemented in a way that preserves access to care, protects beneficiaries, and ensures the program remains financially sustainable for future generations.
Comments